Dear everyone!

This week was the deadline for submitting research groups to the Norwegian Research Council’s evaluation of medicine and health sciences. With good help from Susanna, 10 research groups/centers from K2 were registered: Endocrine Medicine (leader: Eystein Husebye), Research Group for Infection and Microbiology (leader: Rebecca Cox), Oncology (leader: Stian Knappskog), Pharmaceutical Group (leader: Lars Herfindal), Mohn Center for diabetes precision medicine (head: Pål Njølstad), Broegelmann Research Laboratory (head: Helena Erlandsson Harris), Paediatric Follow-up Group (leader: Camilla Tøndel), Bergen Respiratory Research  Group (head: Tomas Eagan), Centre for Pharmacy (head: Reidun Kjome) and Precision Oncology (head: Karl-Henning Kalland). By June 2023, we will receive feedback from the RCN, and in September 2023, a self-evaluation form and impact cases form will be sent out with a deadline of January 2024. Thank you so much to those who take on this job!

Have a really good and sunny weekend!